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THE PRESSURE - THICKENING LOOP: A POTENTIAL APPROACH TO THE 
ASSESSMENT OF TRANSMURAL MYOCARDIAL WORK. Mitchell Todd Saltzberg, 
Lawrence Young, Qing Xin Shi, Albert J. Sinusas (Yale University School of 
Medicine; Section of Cardiovascular Medicine, Department of Medicine, New 
Haven, CT) 
Regional myocardial work can be determined from analysis of pressure- 
length loops derived using implanted paired ultrasonic crystals. A recently 
developed epicardial Doppler thickening crystal (DTC) technique offers an 
atraumatic means of assessing myocardial thickening at the sub-transmural 
(endocardial (EN), midwall (MW) and epicardial (EP)) level. We employed the 
DTC technique in 5 open chest dogs subjected to graded dobutamine (DB)(2.5 to 
15 ug/kg/min) stress, to determine if the area of transmural (TM) and sub¬ 
transmural pressure-thickening loops (PTL) provided an index of regional 
work. Sub-transmural PTL were generated in the left anterior descending 
(LAD) perfusion territory and correlated with sub-transmural LAD 
microsphere flow, cardiac output (CO), hemodynamic indices of myocardial 
work (rate-pressure product (RPP) and maximal dP/dt (dP/dt)), and regional 
oxygen consumption (MVO2). MVO2 was determined from analysis of paired 
arterial and great cardiac vein blood samples. DB (10 ug/kg/min) caused an 
increase in; TM flow (baseline(B): 0.97+/-0.1 4 ml/min/gm; DB: 2.08+/-0.47 
ml/min/gm), TM % thickening fraction (%TF) (B: 1 6.71 +/-3.4 %; DB: 27.7+/- 
1.8%), CO (B: 2.5+/-0.3 1/min; DB: 4.5+/-0.6 1/min), RPP (B: 14941 + /-2 1 5 1; DB: 
25377+/-1032), dP/dt (B: 1800+/-329; DB: 4614+/-731) and MVO2 (B: 10.7+/-2.4 
ml 02/min/100 gm; DB: 13.3+/-0.8 ml 02/min/100 gm). The serial changes in 
the area of the LAD TM PTL correlated with the changes in TM flow (r=0.63, 
p<.05), RPP (r=0.65, p<.0 1), dP/dt (r=0.8 1, p<.0 1), and regional MVO2 (r=0.52, 
p<.05). Changes in LAD TM flow also significantly correlated with changes in 
RPP (r=0.9 1, p<.0 1), dP/dt (r=0.86, p<.01) and regional MVO2 (r=0.89, p<.0 1), 
supporting the use of sub-transmural flow as an indirect index of sub¬ 
transmural work. The changes in LAD sub-transmural PTL area significantly 
correlated with flow changes in the MW (r=0.57, p<.05) and EP (r=0.68, p<.0 1) 
but not EN (r=0.26. p=NS) sub-regions. 
Thus, regional PTL area correlated with regional flow and accepted 
indices of both regional and global work. The correlation of sub-transmural 
PTL area with sub-transmural flow suggests that PTL analysis holds promise as 
a potential index of changes in sub-transmural myocardial work. 
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Several approaches to the assessment of regional myocardial function 
have been taken both clinically and experimentally. A recently developed 
Doppler based technique to measure contractile function is thought to be a 
more reliable, reproducible and physiologic method to assess regional 
function. This approach provides a unique layer by layer assessment of 
transmural thickening. The purpose of this thesis is to evaluate the potential 
role of a novel methodology for the assessment of regional cardiac work at 
multiple levels by examining the relationship between transmural thickening 
and left ventricular pressure. We have preliminarily tested this approach to 
cardiac work in normal animals under conditions of increased demand. In this 
paper, the background which provides the framework from which this 
method of analysis was developed as well as potential applications on the 
clinical level will be outlined with an emphasis on the methodologies 
undertaken. 
Clinical Perspective 
Accurate clinical risk stratification based on myocardial viability and 
function is critical to the proper management of patients with coronary 
artery disease. This is especially true in the post myocardial infarction patient 
where the need to assess viability is paramount. While infarcted myocardium 
is known to be rendered nonfunctional, the consequences of an ischemic 
insult to the myocardium insufficient to cause necrosis may still result in a 
deterioration in function which may persist for an extended period of time 
after the initial insult. This functional deterioration associated with transient 
ischemia has been described by several authors as myocardial "stunning" [1- 
41. Inherent to this concept of "stunning" is a dissociation in the relationship 
between myocardial flow and function. Braunwald first summarized this 
concept in 1982 where he described "stunning" as a situation in which: 
"An ischemic insult not of sufficient severity or duration to produce 
myocardial necrosis may acutely affect myocardial repolarization and 
cause angina (hit); but these changes wane rapidly (run), when the 
balance between myocardial oxygen supply and demand has been 
reestablished. However, the ischemia may interfere with normal 
myocardial function, biochemical processes and ultrastructure for 
prolonged periods (stun).[11" 
The duration of myocardial dysfunction is directly related to the 
duration of the initial ischemic insult. From the clinical standpoint, several 
authors have described the delayed recovery of cardiac function either after 
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thrombolytic therapy [5-7] or during and after percutaneous transluminal 
coronary angioplasty (PTCA) [8] to support the clinical existence of 
"stunning". From the experimental standpoint, data exist which demonstrate 
that periods of brief (less than 20 minutes) experimental coronary occlusion 
result in a functional deficit which only gradually resolves, taking from 
several hours to several days to fully recover depending on the duration of the 
initial insult [9], 
Another concept that has both clinical and experimental support is that 
of "hibernating myocardium." This term was first introduced by Rahimtoola 
in his 1985 summary of data from three large multicenter randomized clinical 
trials of coronary artery bypass grafting (CABG) surgery for chronic stable 
angina [10]. This term was introduced to describe the situation in which: 
"...there is a prolonged subacute or chronic stage of myocardial 
ischemia that is frequently not accompanied by pain and in which 
myocardial contractility and metabolism and ventricular function are 
reduced to match the reduced blood supply." 
In contrast to the concept of "stunning", hibernation is thought to 
represent a balance between flow and function. Bristow proposed that 
myocardial ischemia is a regulated process which serves "...to protect the 
anatomic and physiologic integrity of the cardiac cell" through a down- 
regulation of function and re-establishment of a metabolic balance [11], Ross 
extended this concept when he emphasized the role of regional, as opposed to 
global ischemia in describing how flow and function are highly coordinated 
[12]. Clinical examples have served to illustrate this phenomenon in patients 
who are either post-CABG in whom functional recovery occurs with 
revascularization [131, or who demonstrate enhanced myocardial function 
with inotropic stimulation despite the presence of flow-limiting coronary 
stenoses (i.e. contractile reserve phenomenon) [14], Although experimental 
models of myocardial stunning have been easy to generate, developing models 
of hibernation has proven more difficult. Models by Matsuzaki and Edwards 
using the in vivo doe heart [15, 16] and Liedtke using the extracorporeally 
perfused pig heart [17] have approached hibernation by looking at the flow 
function relationship in response to short-term reductions in coronary 
perfusion. 
Need to Asse-saJunction 
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Central to the concepts of both "stunning" and "hibernation" is the 
assessment of cardiac function. Determination of function can be divided into 
(1) measures of global function and (2) measures of more regional function. 
Measures of purely global function center around the hemodynamic 
performance of the heart. One of the most basic measures of global function is 
the maintenance of forward flow of blood through the heart into the great 
arteries. This is typically measured as the cardiac output expressed as (liters of 
blood)/minute or cardiac index (l/min/m^), which is the cardiac output 
corrected for the surface area of the individual. A second global index of 
cardiac function is the stroke volume, which is the difference in ventricular 
blood volume between end-diastole and end-systole. A third related measure of 
global ventricular function is the ejection fraction of the ventricle, defined as 
the stroke volume divided by the end-diastolic volume. These load dependent 
measures of function are not capable of providing information about 
ventricular function at the regional level since they represent the total 
efforts of all portions of the ventricular chamber. 
Methods which assess both global and regional function, are also 
available. First, the use of echocardiography (ECHO) in the clinical and 
experimental setting to assess function has provided valuable information 
regarding (1) global performance as assessed by the ejection fraction, (2) 
regional wall motion, and (3) wall thickening [18-20], This technique is 
advantageous because it is non-invasive, relatively inexpensive and 
expeditious. Second, equilibrium and first pass radionuclide ventriculography 
(RVG) at rest and with exercise is useful for both the detection of regional and 
global wall motion abnormalities and determination of left ventricular 
ejection fraction with increased reproducibility over ECHO. Finally, the use of 
left ventricular contrast angiography to assess wall motion provides yet 
another means to assess left ventricular function. 
On the forefront of cardiac imaging today is the use of either (1) gated 
magnetic resonance imaging for the high resolution detection and tracking of 
regional wall motion and (2) cine-computed tomography which also provides 
for high resolution detection of regional wall motion and chamber volumes 
with the caveat of radiation exposure to the patient [21]. 
Inotropic Manipulation of Function 
Inotropic stimulation in conjunction with analysis of regional or global 
function has been useful for the estimation of myocardial viability. Inotropic 

agents (e.g. isoproterenol(ISO) and dopamine (DOPA)) have as their primary 
route of action, stimulation of beta-1 receptors in the heart. These receptors 
modulate the contractile and chronotropic state of the heart [22]. The use of 
these inotropic agents has proven to be most useful clinically to not only 
maximize cardiac function in a variety of settings, but also as a diagnostic tool 
to detect the presence of contractile reserve as a marker a cardiac viability [14, 
23-251. 
Further work in the experimental setting has examined the role of 
either ISO or DOPA stimulation in the setting of experimental "stunning" [26- 
28], and low-flow ischemia [25, 29, 30], In these experimental settings 
however, inotropic stimulation (ISO>>>DOPA) was occasionally found to 
paradoxically depress perfusion and function in an area distal to critical 
coronary stenosis, presumably due to the induction of ischemia potentially 
related to the strong chronotropic effects of these agents. Inotropic agents 
have since been modified to provide the maximal inotropic stimulus while 
attempting to avoid the chronotropic, arrythmogenic, and vascular properties. 
In 1975, Tuttle an Mills introduced dobutamine (DOB), which had been 
chemically derived form isoproterenol [31]. Dobutamine has since found its 
way into a number of clinical uses, including: (1) the setting of acute 
myocardial infarction to improve or maintain adequate cardiac function [32, 
33] (2) the setting of chronic progressive coronary disease and heart failure 
[23, 34, 35] and (3) the setting of non-invasive cardiac imaging with ECHO and 
or nuclear cardiac scanning to detect ischemia and/or assess viability [36-38, 
99], In contrast to ISO , in experimental models of infarction and "stunning", 
DOB has been found to consistently augment function in ischemic regions [25, 
30, 39-41] . Thus, it is felt that dobutamine may be the preferable inotropic 
agent to maintain function and, when used in conjunction with various 
cardiac imaging procedures, provide useful diagnostic information. 
Experimental Approaches to Function 
There exists experimental approaches to function which permit a 
higher resolution approach to cardiac function than techniques discussed 
thus far. Among the most widely applied of these techniques are (1) the use of 
two paired ultrasonic crystals to examine wall thickening and/or segment 
shortening and (2) the use of a single epicardial Doppler crystal technique to 
obtain wall thickening data. 
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The ultrasonic two-crystal technique measures dimension by sensing 
the time required for a sound pulse, which is generated by one of the 
transducing crystals, to traverse the medium (myocardium) in which it is 
applied, and be received by the second crystal. To sense the distance between 
the two crystals, the time required for the sound pulse to travel from one 
crystal to the other is divided by the speed of sound through the intervening 
tissue (i.e. x(dist) = (transit - time)/{transit - speed)). This technique can be 
applied in one of two ways. First, both crystals can be implanted at the same 
depth in the myocardial wall along any of the cardiac axes to measure segment 
length changes during the cardiac cycle. Second, it is can be used to measure 
wall thickening at any depth of the myocardial wall by simply placing one of 
the crystals at a given depth in the myocardial wall, and placing the other on 
the epicardial surface. Thus, any displacement which takes place across 
between the two crystals during the cardiac cycle will represent the change 
in wall thickness. The potential advantages of this technique lie in its ability 
to detect (1) absolute distances of either segment length or wall thickening 
and (2) measures of wall thickening at multiple regional locations at the same 
time. The disadvantages of the two crystal technique are: First, to function 
correctly, the crystals must be properly aligned to achieve optimal signal 
transmission and reception. Second, the implantation of the crystals, up to 2 
mm in diameter is traumatic to the cardiac wall and may distort the local fibers 
in such a way as to make measurements on absolute dimension unreliable [42], 
A more recently developed technique to assess myocardial thickening is 
based on the pulse-echo mode of operation common to the two crystal method 
described above. This method, however, uses a single epicardial crystal, 
functioning as both transmitter and receiver by means of an adaptation of the 
pulsed Doppler theory of operation originally applied to sense blood flow 
velocity. The Doppler effect is based on the fact that "When an emitted sound 
beam is reflected from a moving target to a stationary receiver, the frequency 
of the received echo signal if different from the frequency of the original 
emitted signal" (i.e. the frequency is Doppler shifted) [43], The single 
epicardial based crystal has a variable "range-gated sample volume" which 
allows the operator to sample the Doppler shift produced at any layer across 
the myocardial wall. 
By (1) measuring this Doppler shift in frequency produced by the 
movement of myocardial layers passing back and forth through the range 
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gated sample volume, and (2) keeping track of the direction and motion of 
these displacements and integrating the velocity of movement, one can 
reconstruct the displacement of myocardial layers at the preset sample depth. 
The advantages of this technique are multiple. (1) The crystal is applied 
without trauma to the myocardial wall, only three to five superficial sutures 
being required to secure it. (2) No alignment is required with a second 
transducing crystal. (3) Ease of application is greater since only one crystal 
need be applied. (4) Perhaps most importantly, this technique allows for the 
range-gated sample volume to be advanced stepwise across the myocardial wall 
to measure wall thickening discretely at various depths. It is this application 
of the technique which is being utilized in this thesis project to allow for the 
measurement of cardiac work on a sub-transmural basis. 
The major disadvantage of the technique is the fact that, in contrast to 
the two crystal method, the absolute displacement in millimeters cannot be 
determined since only dynamic changes in wall velocity are being measured. 
This technique has been validated against the two crystal technique by 
placing the Doppler crystal on the epicardial surface of the heart and 
positioning a standard ultrasonic crystal within the myocardial wall opposite 
the first crystal. The intra-myocardial crystal was then connected to a module 
designed to receive the Doppler pulse emitted by the epicardial crystal. Thus, 
simultaneous measurements could be obtained via either (1) the single 
epicardial crystal method or (2) by the two crystal method using the same 
epicardial crystal this time, however, as the transmitter in a dual crystal setup. 
The waveforms and calculated thickening fractions were found to compare 
favorably between the two methods under conditions of normal perfusion and 
cardiac ischemia [42, 44]. 
This Doppler based method has since been applied experimentally to a 
model of "stunned" myocardium [45, 46] and clinically to monitor cardiac 
function in patients who are undergoing cardiac surgery [47], The successful 
use of this technique to assess thickening in these situations indicates the 
value of this method in both the clinical and experimental setting. 
Assessment of Transmural Function 
One of the key applications of the above techniques has been the 
examination of the contractile function across the myocardial wall. Sabbah 
was first able to demonstrate using the two crystal technique that the inner 
half of the myocardial wall undergoes substantially more thickening (" 4:1) 

than the outer half of the wall [48]. When Hartley first proposed the Doppler 
based method, he suggested that thickening was actually uniform across the 
myocardial wall [42]. However, later work by Zhu et al. using the same Doppler 
technique came to the conclusion that contractile function was in fact, 
nonuniform, with the endocardium thickening to a greater extent than more 
superficial layers [44]. This transmural gradient in contractile function has 
been supported by other authors using either the two crystal transit time 
technique [49, 50] or pulsed Doppler epicardial crystal technique [16]. It was 
demonstrated that under conditions of non-transmural ischemia produced by 
partial coronary occlusion, a dissociation of myocardial flow and function may 
occur in the epicardium [16]. This type of transmural analysis of function has 
given new insight into the contractile process with the promise of providing a 
better understanding of how contractility is regulated under changing 
conditions of supply and demand. 
Importance of Flow 
To fully address the concept of transmural function, one needs to discuss 
the role, regulation, and distribution of myocardial perfusion. On the simplest 
level of understanding, function cannot be sustained in the absence of blood 
flow. In the case of the in vivo working heart, this blood flow requirement is 
quite substantial. For an organ which weighs about 0.2% of body weight, it 
uses about 4.0% of the total body oxygen consumption which it extracts at a 
rate of 65-85% from the blood which passes through it [5 11. To maintain this 
tremendous demand for blood, the coronary circulation has an elaborate 
system of autoregulation whose ultimate goal is to maintain perfusion under a 
wide range of conditions in sufficient quantity to provide the oxygen required 
for normal cardiac function despite wide variations in demand. The inotropic 
agents, which are known to augment function and therefore demand, have 
been shown to produce parallel increases in perfusion across the ventricular 
wall as myocardial work and oxygen consumption increase, as long as 
coronary autoregulation is intact [51]. 
Methodoloeic Approaches to Flow 
The documentation of myocardial flow in the laboratory setting has 
been extensively studied. It has now become a standard practice to assess 
myocardial flow using the radioactive microsphere method first proposed by 
Rudolph and Heymann [52], Briefly, this method involves the injection of a 
suspension of radiolabeled particles into the left atrium, to ensure adequate 

mixing with blood, while simultaneously withdrawing a reference sample 
from the peripheral circulation. The reference sample is drawn at a known 
and constant rate. By subsequently comparing the counts in the reference 
sample with the counts in the myocardial sample, the myocardial flow can be 
determined. It has been shown that the microspheres are trapped in the small 
terminal vessels in the myocardium where they remain fixed without 
disturbing the native circulation. Furthermore, the microspheres are 
distributed to all organs in proportion to the regional blood flow that they 
receive [53, 54], 
Markers of Function 
The role of transmural perfusion and function has been extensively 
studied in a wide variety of experimental settings. In 1963, several articles 
were published which looked at the oxygen consumption, as an independent 
marker of myocardial work, and global coronary blood flow in a variety of 
canine models. The results of these experiments were indeterminate, as some 
investigators documented parallel changes in oxygen utilization with changes 
in coronary blood flow [55-57], while others did not [58, 59], Work by Daniell 
in a canine model looked at the role of global flow reductions on both oxygen 
consumption and contractile force as measured with an epicardial strain 
gauge. This study reported a significant correlation between the coronary 
flow and both contractile force and oxygen consumption [60]. 
Later work by other investigators looked at the relationship between 
wall thickening as a marker of function and transmural flow was able to 
discern that more specifically, the blood flow to the endocardium correlates 
best with transmural function [16, 61-651. These studies provide evidence that, 
while flow and function may be closely matched under normal conditions, 
regional dissociation between these two variables may exist when examined 
transmurally under conditions of ischemia. 
Pressure-Volume Analysis 
A third line of investigation into functional markers began with Suga 
in 1980 [66] with the use of the area traced by an X-Y plot of changing left 
ventricular pressure vs. changing left ventricular volume (P-V 
DiagramMFigure 1). The pressure-volume area (PVA) inscribed by this 
diagram represents the total mechanical energy generated by a cardiac 
contraction. This includes both external work the heart does to generate 
forward movement of blood and potential energy which is stored as elastic 
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energy in the ventricular wall [67], This potential energy can be used to 
contribute to the mechanical work under certain conditions [68], The 
external mechanical work that the ventricle performs during a contraction is 
represented by the area inscribed by the counter-clockwise rotating lines of 
isovolumetric contraction/relaxation phases and the ejection/filling phases of 
the cardiac cycle (67). The initial and subsequent studies were able to 
demonstrate that the PVA was linearly related to the oxygen consumption of 
the left ventricle under a variety of conditions [67, 69, 70). 
Further analysis of the pressure-volume relationship revealed that by 
tracking the end systolic point in the P-V diagram under different loading and 
contractility conditions, a relation could be derived which was called 
appropriately, the End-Systolic Pressure Volume Line whose slope, (Emax). was 
found to be a powerful index of contractility [67, 69], The use of various end- 
systolic based indexes have since been applied in different experimental 
settings for comparison. These include the development of end-systolic 
pressure-length [71,72], left ventricular dimension-wall thickness [731 and 
stress-strain indexes [72], The above indexes have been found to be 
comparable under most conditions for the accurate assessment of contractility. 
Pre.&s.urg=Leneth Analysis 
The use of the PVA to measure cardiac work and predict oxygen 
utilization can only serve as a global index since it depends on the pressure 
and volume within the ventricular cavity. It fails to provide independent 
information about function and work at the regional level. The earliest 
attempts to assess regional function via loop analysis came with Tyberg in 1973 
with the development of the clockwise rotating pressure-length loop 
generated using an epicardial mercury-filled silastic length gauge [74, 751. 
Their analysis concluded that the area inscribed by this loop represented the 
mechanical work produced by a given cardiac segment during the cardiac 
cycle. Furthermore, by analyzing the morphometries of these loops under 
ischemic conditions, information could be derived about the temporal 
sequence of contraction at various regions in the heart . The onset of ischemia 
was heralded by systolic lengthening with a sharp decline in the area of the 
pressure-length loop and actually reversal of the rotation of the loop. With 
severe ischemia, the ischemic segment was found to stretch passively during 
ventricular systole, providing evidence that the energy generated by the non- 

ischemic segments was being dissipated into the ischemic segment (See Figure 
2) [751. 
A more recent investigation by Vinten-Johansen examined the 
relationship between the MV02, transmural segmental work and segment 
shortening (SS) after repetitive occlusion-reperfusion periods in the dog 
using the pressure-length loop. These authors noted a sharp decline in SS and 
pressure-length loop area with LAD occlusion, although a positive loop area 
(i.e. positive segmental work) was still generated despite akinesis and even 
dyskinesis in the segment. In addition, the MVO2 declined but did not go to zero 
despite the profound changes in SS. These findings were taken as evidence 
that the discrepancy between SS and MVO2 is partially due to the persistent 
development of segment work by the ischemic segment [76]. 
In 1991, Safwat et al. generated pressure-length loops using the two 
crystal ultrasonic technique to obtain their segment length data. In this 
analysis, the loops were analyzed with reference to both the end-systolic and 
end-diastolic time points (Figure 3). Three distinct periods were delineated 
within the loops: these were (1) the effective shortening area (ESA) 
occurring during systole (2) the post systolic shortening (PSS) area and (3) 
the segment lengthening area (SLA) occurring in early diastole. They 
concluded that only the effective shortening area was sensitive to ischemia, 
even more so than the total loop area [77], A novel clinical application of the 
pressure-length loop has also been described whereby changes in segment 
length were obtained form left ventriculograms using a radial analysis to 
detect centripetal movement of the endocardial surface [78]. 
In an attempt to overcome the difficulty in measuring segment length 
in the clinical setting, Nakano et al. introduced a mathematical means to assess 
regional work which incorporates the wall thickness. The equation derived 
was RWM - -J od[\n{\ / //)] , where <7 = stress as defined by P x D/411, 
P=ventricular pressure, D=ventricular diameter and wall thickness, both of 
these dimension parameters being determined by ECHO. This technique has 
been validated in an animal model and was shown to reliably provide 
information about the regional work in both normal and coronary artery 
disease patients. 
Hypothesis 
Few investigators have thus far been able to relate the three variables 
of (1) contractile function, (2) myocardial perfusion and (3) cardiac 

metabolism on the regional level with much success. This project was designed 
to gain further insight into the regional interrelationship of these variables. 
The Doppler based epicardial crystal technique of measuring sub-transmural 
myocardial thickening will be employed to generate left ventricular pressure- 
thickening loops as a novel approach to determining regional work. The area 
of the pressure-thickening loop will be related to flow, oxygen metabolism, 
and hemodynamic parameters of function at the transmural level and then 
subsequently at each level of the myocardial wall (i.e. endocardial, midwall, 
and epicardial) by relating the changes in work to the changes in flow. It is 
hoped that the ability of the Doppler technique to interrogate discrete layers 
across the wall will allow for the first time, the assessment of work on a sub¬ 
transmural basis with both accuracy and reproducibility. We propose to test 
this hypothesis in a normal canine model with graded dobutamine stress to 
examine work under different levels of inotropic stimulation. 

Materials and Methods 
Surgical Preparation: 
Fasted mongrel dogs of either sex, weighing between 40-50 pounds were 
pre-medicated with atropine (0.07 mg/kg) and ketamine (10 mg/kg), then 
given by rapid intravenous bolus, sodium thiamylol (20 mg/kg) to induce 
rapid anesthesia. The animals were immediately intubated by direct 
laryngoscopy and ventilated on a pressure ventilator with a tidal volume of 20- 
25 cc/kg. Anesthesia was maintained with a 70:30 N20:02 mixture with 
halothane (.5-1.5 %) to a level at which (1) the eye blink response was 
abolished (2) no response was noted with surgical incisions and (3) no 
resistance to the function of the ventilator was observed. 
The animals, once fully anesthetized were instrumented as follows. The 
limb leads of the electrocardiogram were placed to monitor the 
electrocardiogram. Bilateral groin dissections were performed to expose both 
femoral arteries and one femoral vein. A pair of 8F stiff-walled catheters were 
placed in one femoral artery, and a third catheter was placed in the other 
artery. An additional catheter was placed in a femoral vein to facilitate fluid 
administration. One 8f catheter from each femoral artery was reserved for 
arterial withdrawal during the administration of radiolabeled microspheres 
for flow, the third being used to monitor systemic pressure. A ventral midline 
abdominal incision was made to gain access to the urinary bladder for 
subsequent catheterization. The left neck was dissected for isolation of the 
external jugular vein and left common carotid artery. An introducer was 
placed in the common carotid artery to allow for the retrograde passage of a 
high fidelity Millar® micromanometer catheter to a sub-aortic valve position 
for measurement of left ventricular pressure and dP/dt. A 6f catheter was 
placed retrograde into the coronary sinus via the external jugular vein and a 
Swan-Ganz catheter was placed by the same route into the pulmonary artery to 
facilitate monitoring of body temperature, right atrial pressure and cardiac 
output by the indicator dilution method. 
A left thoracotomy was then performed via the fifth intercostal space to 
expose the heart. The pericardium was opened and the heart suspended by a 
pericardial cradle. The left lung was retracted using an unfolded 4x4 gauze to 
facilitate access to the heart. A silastic catheter was placed into the left atrium 
via the left atrial appendage for the administration of radiolabeled 
microspheres and monitoring of left atrial pressure. 

The proximal left anterior descending (LAD) coronary artery was 
dissected free, taking care to not disturb any septal branches, above the 
bifurcation of the second major diagonal branch to allow for placement of the 
Doppler flow probe and snare occluder. 
Finally, Doppler thickening crystals were sutured to the epicardial 
surface in both of the regions supplied by the LAD and left circumflex 
coronary artery (LCX) using three to four 6-0 sutures penetrating the 
epicardial surface to a depth of 0.5-1.0 mm. 
Theoretical Considerations of Doppler Based Method 
As measurement of both proximal LAD flow and myocardial thickening 
in this animal preparation are based on the Doppler principle, the theoretical 
foundation of this technique will now be addressed. 
The Doppler effect, as stated earlier, depends on the change in 
frequency of an emitted sound pulse produced by a moving object, which is 
detected by a stationary receiver. In the special case where a single 
transducer acts as both emitter and receiver, an equation exists which 
describes the relation between the velocity of the moving object and its 
Doppler shift: 
V = (A/ x c) / 2 x fo x (cos a) (equation 1) 
Where fo=transmitted frequency (Hz), V=velocity of the reflector (m/sec), 
c=speed of sound in the medium (m/s), cr= angle between the direction of the 
emitted sound beam vector and velocity vector of the reflector and A/=change 
in frequency produced by the moving reflector. For the flow probes used in 
this experiment, the angle a is fixed at 45 degrees by mounting the Doppler 
crystal in the silastic and wax housing which fits around the vessel. Since f0 = 
20 Hz and the velocity of sound within the vessel is constant at 1500 m/s, then 
by substitution equation 1 becomes: 
Vmax(cm/sec) = 5.3 x A/(KHz) (equation 2) 
The Doppler flow probe operates by emitting pulsed bursts of sound 
separated from one another by 16 usee into the blood vessel where they are 
reflected by the moving blood cells and received at a Doppler shifted 
frequency back at the probe. A useful means to describe the distance between 
transmitted pulses is to use the inverse of the period, commonly referred to as 
the Pulse Repetition Frequency (PRF) (i.e. PRF = (.016 sec) "1 = 62.5 KHz). The 
time required for the sound echoes to be received is described by the equation: 
t = 2 x (d/c ) (equation 3) 

Where t = time delay (sec), d = distance between the transducer and the 
reflector (m), and c = speed of sound in the medium (1 500 m/sec). The receiver 
selectively samples the echoes received from within a "sample volume", which 
is a 1 mm^ sensitivity region produced by the crystal. Echoes are sampled for a 
period of time whose length is defined by adjusting the "range-gate delay." 
For example, adjusting the range gate delay will move the sample volume to 
various positions across the vessel wall, thus proportionately changing the 
period of time during which echoes are received to allow for selectively 
sampling of flow at various vessel positions. The echoes which are received by 
the probe are then amplified and compared in phase and frequency to that of 
an internal reference oscillator which operates at the acoustic carrier 
frequency (f0) of 20 MHz. The 20 MHz acoustic frequency chosen for this 
system, has been found to balance the tradeoff between the high acoustic 
scattering of blood cells which is proportional to the fourth power of 
frequency and the acoustic absorption of blood which also increases with 
frequency. Further, at 20 MHz the signals reflected from blood are strong 
enough to allow for the flow probe to sense velocity at distances from 1-10 mm 
from the crystal face, well within the range of normal epicardial vessel 
diameters. Since blood flow is typically expressed as ml/min, and not m/sec, a 
mathematical means to convert velocity into flow was developed by Hartley 
[79], Under ideal conditions, flow is described by the equation: 
Q(ml / min) = (Vavg(mm / sec)x Area(mm2))x 60 (equation 4) 
Where Vavg = average velocity of flow across the vessel wall. However, since 
cross sectional area is not readily determined in vivo, it was determined that 
under conditions of laminar flow with a parabolic velocity profile, Vavg = 
Vmax/2. By substitution, the flow equation then becomes: 
Q(ml I min) / Af(KHz) = (5.3x Area(mm2) / 2 (equation. 5) 
By setting the Area = d^/4 where d = internal vessel diameter estimated by the 
size of appropriately fitting flow probe, one derives the final equation for 
flow: 
Q(ml / min) / Af (KHz) = 1.25 x d2 (equation 6) 
This method has since been validated with against timed collections of effluent 
blood with a strong linear relationship being found to exist. 
To ensure proper function of the flow probes, several precautions need 
to be taken. First, adequate fit of the flow probe around the vessel ensures that 
the angle between the embedded Doppler flow crystal and vessel axis remains 
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constant at 45 degrees. Proper fit also ensures that the vessel diameter will be 
estimated correctly for use in the velocity to volume calculation. Flow probes 
are supplied in 0.5 mm increments with internal diameters of 2.0-3.5 mm. 
Second, the sample volume needs to be positioned in the center of the vessel 
axis to ensure that maximal blood flow velocity is being sampled. As stated 
earlier, assuming conditions of laminar flow with a parabolic velocity profile, 
this position is easily determined as that at which the signal obtained has the 
greatest amplitude. Third, to avoid deterioration in signal quality from non- 
laminar blood flow, the probes need to be placed at the most proximal position 
on the vessel, typically proximal to the second major diagonal branch and 
snare occluder. The final step to ensure proper function is correct calibration 
of the probe by systematically applying a known Doppler shift frequency 
from which the flow instrument is able to register the appropriate voltage 
reading. 
Working from the same theoretical framework as Doppler based flow 
measurement, Hartley developed the technique to measure wall thickening 
[42]. The Doppler probe consists of a 4 mm disk of 10 MHz piezoelectric crystal 
which has been attached to a circular piece of Gortex® graft material, used to 
secure the probe to the epicardium. The probe operates much like the flow 
probe, by using pulsed sound waves directed perpendicular ( a = 0° from 
equation 1) to the myocardial wall to detect the Doppler shift produced by the 
movement of various myocardial layers within the sample volume during the 
cardiac cycle. The range gated sample volume is adjusted as before to allow for 
interrogation of the various layers across the wall, at depths ranging form 2- 
40 mm. The crystal operates at an ultrasonic frequency of 10 MHz with a PRF 
of 4 KHz (250 usee separation). By comparing the echoes produced by the 
myocardium with those of two internal reference oscillators, the phase 
difference is used to convert back and forth movement in time into up and 
down motion in voltage at the given range delay. In essence, the circuitry 
electronically integrates the velocity of myocardial wall movement to 
determine displacement. 
This method does not depend on the ability to track a discrete interface, 
rather, displacement is measured at a fixed depth. Thus, within the sample 
volume, the myocardial layers present at any given time change throughout 
the cardiac cycle. Layers within the sample volume at end-diastole tend to be 
deeper than those seen at end-systole since the wall has thickened. Since no 
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layer is tracked, the starting point for the phase detection is arbitrary, thus it 
is not possible to measure the absolute thickness, only the relative excursion. 
Furthermore, the final output location along the thickening axis, as it appears 
on the chart recorder bears no relation to the actual thickness of the wall. 
The variable range gate delay is used to set the time delay (3-50 usee) at 
which the phase of the signal is sampled. Since the echoes produced by the 
myocardium are relatively low frequency when compared to those of blood 
flow, the audio echo signals are limited to a band extending from 1 Hz to 1 KHz, 
thus allowing velocities from .075 mm/sec to 7.5 cm/sec to be sensed. For 
comparison, blood velocities usually range from 1 to 100 cm/sec with an 
associated audio band of 100 Hz to 10 KHz [42, 43, 791. The sampled phase 
changes are recorded such that movement toward the probe advances an 
electronic counter, while movement away subtracts from the counter. The 
real time output from the counter is then fed through an analog to digital 
converter which produces the final voltage output which is calibrated to a 
millimeter displacement. The resolution of the system allows for displacements 
as little as .02 mm to be detected. 
To measure wall thickening quantitatively, the % thickening fraction 
(%TF) of the various myocardial layers is determined. By the classic two 
crystal ultrasonic technique, %TF is expressed by the following equation: 
((EST — EDT) / EDT) x 100(equation 7) 
Where EST = end-systolic thickness and EDT = end-diastolic thickness. In this 
preparation, since absolute thickness is not directly possible, a mathematical 
means was developed by Hartley [42], By knowing the value of range gate 
delay (R) in mm, and the total systolic excursion (SE) of thickening in mm, 
%TF is described by the equation: 
%TF = (e(SEIR) -1) x 100 (equation 8) 
Operation of Doppler Thickening System 
As stated earlier, thickening crystals are placed in both the LAD and LCX 
territories for the collection of data. The proper range gate delay, is 
determined by gradually advancing the range gated sample volume until the 
blood pool is detected by a sharp change in the audio signal. The sample 
volume is then brought back to a position where the quality of the signal is 
consistent throughout the cardiac cycle. The maximal depth that the Doppler 
crystal ( as well as the dual crystal ultrasonic crystal technique) is able to 
sample thickening at, has been estimated to be 85% of the total wall thickness 
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[16,94] . As demonstrated in Figure 4, this depth is considered to represent the 
transmural thickening. The total range is then divided in thirds, thus 
allowing signal sampling at two other positions besides the transmural point. 
Since the crystal measures thickening between the level of the sample volume 
and the crystal itself, the three positions across the myocardial wall will 
represent thickening of the: (1) transmural (Tm) or full wall thickness, (2) 
outer two-thirds (Out 2/3) of the wall and (3) outer one-third (Out 1/3) of the 
wall. To avoid placing the crystals, especially the one situated in the LCX 
territory, over a papillary muscle, the range gate at which the blood pool is 
encountered is tracked at various positions within the territory. Papillary 
muscles are easily determined as positions on the myocardial wall at which the 
blood pool location is deeper than expected (e.g. greater than 14 mm). Once the 
crystals are positioned correctly, both the range and thickening are 
electronically calibrated to ensure appropriate function. 
Computer Data Acquisition 
All experimental data are recorded using an eight channel computer 
based data acquisition program referred to as DATAFLOW (Crystal Biotech, 
Holliston MA). The hardware includes a multichannel interface module (VF-1, 
Crystal Biotech) whose output is linked through an analog to digital (A/D) 
converter to a 486(25 Mhz) Computer (Gateway 2000). An oscilloscope is used to 
give a visual representation of the range outputs from both thickening 
crystals and the flow probe. Dataflow is able to interpret the digital output of 
the A/D converter into the appropriate units and reconstruct the channel 
outputs in real time. In addition, Dataflow computes a variety of statistics in 
real time for each channel (e.g. mean, max., min, +/- derivatives etc...) (See 
Figure 5). 
Dataflow collects the data from a total of eight channels during the 
course of each experiment: (1) LAD flow output from the 20 MHz pulsed 
Doppler module in VF-1 (PD-20; Crystal Biotech) (2) LAD Thickening from the 
pulsed Doppler dimension module (DMM-10; Crystal Biotech) (3) Left 
Ventricular Pressure (LVP) from the Millar Micromanometer module (Millar 
Industries) (4) LAD Thickening Range also from the DMM-10 module (5) ECG 
for heart rate from the limb leads of the electrocardiogram (6) Aortic 
Pressure for both systolic and mean pressure from a fluid filled pressure 
transducer output (7) LCX Thickening from the second DMM-10 on the VF-1 
and finally (8) LCX Range from the same module. Dataflow has built in 
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derivation of the first derivative of left ventricular pressure (dP/dt) which is 
displayed simultaneously with the LVP. All eight channels above are also 
directed into an eight channel pen recorder for hard copy record. 
Dataflow provides the ability to save large amounts of data in two 
different formats during the course of a given experiment. The program is 
first able to create a trending file of all channels at user specified intervals of 
10-60 sec. Second, the user can perform manual saves to capture up to eight 
channels of data at specific time points in the experiment. These data are 
stored at intervals of .00221 sec for a total of about 5 seconds to give 300-2400 
data points (1500 for this preparation). These manual saves provide the raw 
data for subsequent analysis. 
Other data not recorded through Dataflow includes: Cardiac Output 
using the Swan-Ganz catheter and Cardiac Output computer (Edwards 
Laboratories, New York, NY), body core temperature from the Swan-Ganz 
catheter, arterial blood gas data every 45-60 min, left and right atrial 
pressures and metabolic data for oxygen content. 
Myocardial Blood Flow Determination 
Regional myocardial blood flow is determined using the radiolabeled 
microsphere referenced withdrawal technique introduced by Rudolph &. 
Hey man in 1967 (52). Microspheres (12 um diameter), supplied by DuPont were 
pre-labeled with the following isotopes: Sn-1 13, Sc-46, Ru-103, Cr-5 1 and Nb- 
95. Prior to injection, the dose of microspheres to be given (average >2 
million) are decay corrected to ensure that the radioactivity injected for each 
flow determination is comparable. The microspheres are mixed with saline, 
vortexed and flushed between two syringes via a three way stopcock to ensure 
an even distribution without microsphere aggregates. 
Prior to injection of the microspheres, the withdrawal pump connected 
to the two 8F femoral artery catheters is started to ensure the smooth return of 
blood. Once constant flow is established, the microspheres are injected into 
the left atrium over a 15-20 second period, followed by 5 cc of saline as a flush. 
The withdrawal pump continues at a constant rate of 5.68 cc/min for 95 
seconds providing paired 9 cc samples of blood. Once complete, an additional 3 
cc of blood from each catheter is withdrawn to ensure clearance of all 
microspheres from the catheter "dead space". It has been shown that no 
microspheres remain in the circulation 60 seconds after injection [54]. The 24 
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cc of blood is evenly divided among 16 vials and weighed in preparation for 
gamma well counting. 
Post-mortem the heart is trimmed to separate the ventricles and septum 
from the rest of the heart. The ventricles are then divided into five (5) slices 
along the short axis from base to apex. The slices are then incubated in a 
solution of triphenlytetrazolium chloride (TTC) at 37 °C for 20 minutes to 
delineate any necrotic myocardium. The slices are photographed and the 
location of the thickening crystals are marked on an acetate template. 
The visceral pericardium and any remaining fat are trimmed in 
preparation for gamma well counting for the determination of regional blood 
flow. The short axis slices are then divided into eight evenly spaced radial 
segments, with each segment then being divided into thirds to separate the 
endocardium, midwall and epicardium. Each slice is placed in a numbered vial 
(1 to 96), weighed and counted in a multichannel gamma well counter (Cobra 
Systems). Separation of the activity for each radiolabeled microsphere by 
specific energy windows was performed according to the method of Heymann 
[54] with the appropriate spill-up and spill-down corrections. 
To determine the myocardial blood flow, the following formula was 
utilized [52]: 
Qm = CmxQref/Crtf (equation 9) 
where Qm = myocardial blood flow (ml/min), Cm=radioactivity in myocardial 
sample (cpm), Qref=reference withdrawal rate (ml/min) and Cref=radioactivity 
in the reference withdrawal sample (cpm). Flow is then corrected for the 
weight of each myocardial sample so that final flow is expressed in units of 
ml/min/gm. 
This technique provides the ability to assess flow at multiple time points 
during the course of single experiment. It has been shown that appropriately 
sized microspheres are permanently trapped in the microcirculation on the 
first pass without causing any hemodynamic compromise [54], 
To facilitate the comparison of flow with the pressure thickening loops 
at the sub-transmural level, only those myocardial sectors which immediately 
surrounded the location of the crystals were used. This typically meant that 
five total sectors were used: (1) at the crystal (2) above and (3) below the 
crystal and to the (4) right (5) and left of the crystal. 
Metabolic Data Processing 
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Using the temporally paired blood samples from the coronary sinus and 
femoral artery, the % saturation of hemoglobin (Hb) was determined using a 
hemoximeter (OSM2 Hemoximeter, Radiometer Copenhagen). The oxygen 
content of each sample was calculated using the Hb concentration and the 
constant 1.33 ml 02/gm hemoglobin. The differences in oxygen content were 
then calculated between arterial and coronary sinus/AIV samples and 
multiplied by regional flow (taken form the five sectors described above) to 
measure the regional oxygen consumption (MVO2). 







|2.5| ^0 ^ 7.5 ^ 1M 15^ < PostD 
uS #2 uS #3 uS #4 uS#5 
MV02 MV02 MV02 MV02 
uS=Microsphere injection for flow 
MV02=Blood sampling for oxygen 
content 
A) A 30-45 minute baseline period with injection of the first 
microsphere for regional flow determination. 
B) Dobutamine, obtained as a stock solution (Dobutrex ®, Lilly) of 250 
mg/20 ml (12.5 mg/ml) was diluted using sterile saline and injected 
into the left foreleg brachial vein using a digitally calibrated 
screw infusion pump to achieve precise infusion rates. 
C) Graded dobutamine infusions were done @>2.5 ug/kg/min (D2.5) for 
10 minutes, @5.0 ug/kg/min (D5.0) for 15 minutes with injection of 
second microsphere for regional flow, @>7.5 ug/kg/min(D7.5) for 10 
minutes, @> 10 ug/kg/min(Dl0.0) for 15 minutes with the third 
microsphere for regional flow determination, and @>15 ug/kg/min 
(D15.0) with injection of the fourth microsphere for flow. 
D) A 15-30 minute period of observation after dobutamine (Post D) was 
concluded was used to monitor recovery and assess myocardial flow 
with the fifth microsphere injection. 

21 
E) The animals were sacrificed using a bolus of 2M KCL with 
subsequent excision of the heart. The heart was then prepared for 
gamma well counting as described above. 
The following data (unless otherwise specified) was collected at 5 minute 
intervals during baseline, twice at each level of graded dobutamine and at two 
points during the 15 minute post dobutamine period. 
(1) Hemodynamic measures: Heart rate, mean aortic pressure, 
right and left atrial pressure, left ventricular pressure with 
its first derivative (dP/dt), LAD Doppler flow, and cardiac output . 
(2) Thickening data: Thickening and range data were obtained 
at the Tm position at the intervals specified above. In 
addition, thickening and range data was obtained at the Out 2/3 and 
Out 1/3 positions twice during baseline, once at each level of 
dobutamine and twice during the post dobutamine period. 
(3) Metabolic measures: Blood samples for oxygen content were 
temporally paired to the determination of regional blood flow with 
radioactive microspheres. 
(4) Arterial blood gas (ABG): ABG's were determined at intervals of 45- 
60 minutes throughout the experiment. 
Derived Data 
In addition to the hemodynamic parameters mentioned above, two 
additional hemodynamic indices were computed. (1) The pressure-rate (P-R) 
product defined as the product of peak aortic pressure and heart rate expressed 
as mmHg x beats/min. (2) The systemic vascular resistance was also calculated 
using the following: 
SVR = {{MAP- RAP) x 80) / CO (equation 10) 
Where MAP = mean aortic pressure, RAP = right atrial pressure and CO = 
cardiac output. 
Data Processing for Pressure-Thickening Loops 
All data processing was performed using Microsoft Excel® on the 486 25 
MHz computer described earlier. Microsoft Excel® is a spreadsheet program 
which allows large amounts of data to be manipulated and plotted. The X-Y 
graphic plots of left ventricular pressure vs. thickening used to create the 
pressure-thickening loops were all generated using this program. The 

following is a narrative description of the steps involved in processing of the 
data. 
A. The raw hemodynamic data derived from Dataflow® consisted of the 
1500 data points with an average of 6-9 complete cardiac cycles. This 
data was first downloaded into Excel® in the form a worksheet. Data 
analysis was restricted to the LAD and LCX thickening data and left 
ventricular pressure (LVP). Using Excel®, a automated program (i.e. 
a "macro") was written to calculate dP/dt for all 1500 data points 
using the following equation: 
dP/dt(mmHg / sec) = (LVPx+l - LVPx)/(time x+l -timex)(equation 11) 
Where x = an arbitrary point in time within the data file. 
B. The thickening signal was first displayed using Excel® to ensure 
signal quality. Five full cardiac cycles were then selected based on 
the dP/dt using the point of initial upstroke as the onset of systole 
and the point immediately preceding the next initial upstroke as the 
end of diastole. In cases where five beats could not be used due to 
either insufficient number of beats per data set or compromised 
signal quality, the maximum number of possible beats were utilized. 
C. The data contained within these five intervals for LADTH, LVP and 
LCXTH was copied to a new Excel® worksheet where it was rearranged 
into columns of thickening and pressure data for each of the 
selected beats using another macro written for this purpose. 
D. Each of the separate thickening signals was then normalized to the 
minimum thickening value for each beat. Thus expressing each beat 
as a net excursion from its minimum value. This step was necessary 
to compensate for the variable position of the signals along the 
thickening axis. As discussed earlier, since the thickening signal 
position bears no relation to the actual thickness, the loops obtained 
prior to normalization could be centered on virtually any value. By 
normalizing, all loops were based on a zero point for consistency. 
D. The average values for five normalized beats were then taken for 
LADTH, LCXTH, and LVP. dP/dt was re-computed based on the average 
LVP for the five beats and time interval between the data points. 
E. X-Y plots were then made using Excel® for mean LADTH vs. mean LVP 
and for mean LCXTH vs. mean LVP to generate the pressure 
thickening loops, each representing the average of the five 
, 
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averaged cardiac cycles.(See Figure 6) This process was repeated for 
each manual save, including those with data for transmural, outer 
2/3 and outer 1/3 thickening during the course of each experiment. 
F. The net systolic excursion was then calculated by taking the 
difference between the maximum and minimum thickening value 
during the systolic interval (where systole is defined by the initial 
upstroke of dP/dt to peak negative dP/dt) for each of the normalized 
beats. The average systolic excursion was then calculated for both 
the LADTH and LCXTH. 
G. By using the average systolic excursion and Doppler range obtained 
from the original data file, the thickening fraction was then 
calculated using the formula (equation 8) derived by Hartley. 
H. To calculate sub-transmural thickening fractions, the difference in 
systolic excursions was then taken such that Endocardial (Endo) = 
(Transmural)-(Outer 2/3); Midwall (Mw) = (Outer 2/3)-(Outer 1/3) 
and Epicardial (Epi) = Outer 1/3. The respective differences in the 
ranges were used in equation 8 to generate the respective %TF for 
each sub-region. 
I. Each of the pressure-thickening loops which was generated was 
then planimetered three times using a SummaSketch® 
(Summagraphics) digital planimeter pad then averaged. The area of 
the loop was expressed in the square number of digital pixels 
occupied by the loop on the planimeter pad. 
J. Similar to the approach to obtain transmural thickening data, 
differences in measured areas were then computed to generate the 
net area values for the Endo, Mw and Epi sub-regions. 
Laboratory Responsibilities 
All surgical responsibilities were divided among this investigator, 
Jonathon Alderman and QingXin Shi. Dr. Albert Sinusas was responsible for 
placement of the coronary sinus venous catheter and assistance with any 
technical problems encountered during the course of the experiment. Dr. 
Lawrence Young was responsible for processing of all metabolic blood 
samples. All data analysis, with the exception of operation of the gamma well 





All statistics were performed using Statview® 512, a statistical and 
graphics program for the Macintosh computers. Correlations were expressed 
as the Pearson (r) correlation. Statistical significance (at least p < .05) was 
determined using a standard significance table with the appropriate degrees 
of freedom [80], 
Results 
A total of seven dogs were used for this study. Two of these animals were 
subsequently excluded from the data set: one secondary to a malfunction of 
the Millar® pressure catheter and the other for technical complications 
related to the surgical preparation. Of the five remaining animals, complete 
data sets are available for three animals. The other two animals lacked either 
complete metabolic or flow data sets. In addition, thickening and loop data 
from the LCX region needed to be excluded for one animal secondary to poor 
signal quality. 
Hemodvnamics(Table 1) 
Summarized in Table 1 are the hemodynamic parameters during the 
experimental protocol. The heart rate, R-P product, maximal value of dP/dt, 
cardiac output and LAD flow as measured with the Doppler flow probe steadily 
increased with graded dobutamine dose. These hemodynamic parameters 
generally returned to values intermediate to those of the baseline and D5.0 
when dobutamine was discontinued. The mean aortic pressure (mean AoP) 
responded differently with an initial increase up to D5.0 after which the mean 
pressure actually declined slightly with further increases in dobutamine. The 
mean AoP then returned to baseline 15 minutes after dobutamine was stopped. 
To further examine changes in the vascular tone during these studies, the 
systemic vascular resistance (SVR) was calculated. With graded dobutamine, 
the SVR steadily declined, from a value of 3708 +/- 242 at baseline to 1989 +/- 
281 at D15.0. 
Regional Microsohere Blood Flow (Table 2) 
The regional blood flow at the Endo, Mw, Epi and Tm levels for both the 
LAD and LCX region are reported in Table 2. Throughout the study, the flow 
across the wall in both perfusion territories behaved identically with 
increasing dobutamine producing parallel increases in flow. In the post 
dobutamine period, however, flow decreased but failed to return to baseline 
levels. Potential explanations for this observation are offered below. 
Thickening Data (Table 3) 
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A representative baseline LAD tracing of the thickening signals 
obtained at the Tm, Out 2/3 and Out 1/3 sampling locations are shown 
superimposed in Figure 7 to demonstrate how thickening increased 
progressively as the Doppler range was advanced from the epicardium towards 
the endocardium. 
The data for the LAD and LCX territories at both the transmural and sub¬ 
transmural levels are summarized in Table 3. The %TF at all levels was found to 
initially increase with dobutamine, then plateau as dobutamine increased. The 
thickening fraction returned to baseline levels once dobutamine was stopped. 
The %TF for the Endo, Mw and Epi exhibited a transmural gradient 
favoring the deeper myocardial layers in both territories throughout the 
experiment. With graded dobutamine, the %TF for the Endo and Mw tended to 
equalize in both the LAD and LCX regions, while consistently remaining 
higher than the %TF for the epicardium. 
Pressure-Thickeninfi Loop Area (Table 4) 
Sub-transmural work was estimated by analysis of the pressure¬ 
thickening loop areas. The changes in these loop areas for both the LAD and 
LCX regions are summarized in Table 4. A typical LAD Tm (full wall thickness) 
pressure-thickening (P-T) loop at peak dobutamine is illustrated in Figure 6 . 
All area measurements of P-T loop areas are expressed in units of square pixels 
occupied on the digital planimeter pad described earlier. 
There was a different response in the loop areas to dobutamine in the 
LAD and LCX regions. With graded dobutamine, the LAD Tm loop area, and 
therefore work, progressively increased with each level of dobutamine while 
the LCX Tm work plateaus after D 2.5. Further sub-transmural analysis 
demonstrated that: (1) Dobutamine greatly increased work when compared to 
baseline although in a nonlinear manner. (2) At all times, the work performed 
by the Endo and Mw was greater than that performed by the Epi. (3) At 15 
minutes after dobutamine, work declined although did not return to pre- 
dobutamine levels in all animals. 
Metabolic Data 
The regional oxygen consumption (MV02)(ml 02/min/100 gm) for the 
LAD perfusion territory was calculated as a independent metabolic measure of 
regional work. With graded dobutamine the MV02 increased steadily from 




13.25 +/- 0.77 at D15.0. With the cessation of dobutamine, the MV02 declined 
towards baseline to a value of 9.20 +/- 0.80. 
Loop Areas and Indices of Myocardial Work (Table 5) 
To evaluate the use of the P-T loop as an index of work, correlations 
were sought between the Tm loop area in the LAD and LCX region and either 
the MVO2 (LAD only), R-P Product, or maximal dP/dt. All data points were 
expressed as a % change from baseline in order to facilitate the incorporation 
of multiple animals into the same data set. These three variables were used to 
compare the P-T loop to both regional (MVO2) and global (R-P product and 
maximal dP/dt) indices of work. As seen in Table 5, a fair (r=.524)(p<.05) 
correlation exists between the LAD Tm loop area and regional MVO2 (Figure 8 
a) . Comparisons between the Tm loop area and the hemodynamic indices of 
work revealed significant correlations between the LAD Tm loop area and both 
the P-R Product (r=.648)(p<.01) and max. dP/dt (r=.8 14)(p<.0 1 XFigures 8 b-c). 
Equally significant correlations were found between the LCX Tm Loop area and 
max. dP/dt (r=.822)(p<.0 1) and P-R Product (r=.9 17)(p<.0 1 XFigures 9 a-b). 
Blood Flow Relations to Loop Area and Indices of Work: (Table 5) 
The relationship between both LAD and LCX transmural flow was then 
compared, after normalization baseline as before, to the same three markers of 
function as above. In each case, there an excellent correlation found to exist 
between the LAD transmural blood flow with either the (1) MVO2 
(r=.886)(p<.01) (2) P-R Product (r=.9 12)(p<.0 1) or the (3) max. dP/dt 
(r2=.863)(p<.0 1 XFigures 10 a-c) and LCX transmural blood flow with both the 
(1) P-R product (r=.90 1 )(p<.0 1) and (2) max. dP/dt (r=.871 )(p<.01 XFigures 11 a- 
b) . Transmural flow was also related to the area of the P-T loop area with 
significant correlations being demonstrated for the LAD (r=.633)(p<.05)(Figure 
10 d) and LCX (r=.879)(p<.0 1 XFigure 11 c) territories. 
To evaluate the P-T loop area as an index of change in sub-transmural 
work, comparisons were sought between microsphere flow and loop area at the 
Endo, Mw and Epi levels for both the LAD and LCX territory. Microsphere flow 
was used as the comparative index of work based on (1) the strong correlations 
noted between the transmural flow and both metabolic and hemodynamic 
indices of work and (2) the lack of appropriate metabolic and hemodynamic 
indices of work at the sub-transmural level. As shown in Table 5 and Figures 
12 a-c, for the LAD territory, significant correlations between microsphere 
flow and loop area were noted only for the midwall and epicardial sub-regions, 
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with a non-significant positive correlation noted for the endocardial sub- 
regions: endocardium (r=.256)(p=NS); midwall (r=.572)(p<.05); epicardium 
(r=.68 1 )(p<.01). In contrast, Table 5 and Figures 13 a-c demonstrate that for the 
LCX territory, significant correlations were noted only in the endocardial and 
epicardial sub-regions, with a non-significant positive correlation found for 
the midwall sub-region: endocardium (r=.9 17)(p<.0 1); midwall (r=.523)(p=NS); 
epicardium (r=.766)(p<.0 1). 
Discussion 
In this study, we have demonstrated that analysis of regional left 
ventricular pressure-thickening loops holds promise as a reliable index of 
changes in cardiac work. These loops were generated using a new Doppler 
based epicardial thickening crystal which provided for the ability to 
discretely sample the thickening at the level of the endocardium, midwall and 
epicardium. The transmural loop area was found to correlate significantly 
with transmural myocardial blood flow, MV02 and accepted hemodynamic 
indices of global myocardial work. In addition, strong positive correlations 
were found between the transmural flow and these same indices of work 
supporting the use of flow as an indirect index of work at the sub-transmural 
level. Finally, the Endo, Mw and Epi P-T loop areas were examined with respect 
to their sub-transmural blood flow where in general, significant correlations 
were noted. It is therefore the conclusion of this thesis that the left 
ventricular pressure-thickening loop may prove, with further analysis, to be 
a reliable index of changes in regional work at a level of analysis not 
previously available. 
Loop Area Analyses with Comparisons to Indices of Work 
Suga has extensively studied the use of the pressure-volume loop area 
(PVA) as an index of cardiac work by relating it to myocardial oxygen 
consumption [67, 69], The correlation reported between these variables was 
higher (r^=.98) than that reported in this study (r2=.274). One potential 
explanation for this discrepancy is that the model used by Suga, in contrast to 
that used here, was that of an ex vivo canine-excised, cross-circulated heart 
where pressures and volumes could be precisely controlled. A second possible 
explanation lies in the fact that the pressure-volume analysis is by definition, 
a more global assessment of work than the P-T loops generated in this project. 
It is possible that the MVO2 and work at the regional level ( i.e. using the 
pressure-thickening analysis) may show local heterogeneity, the details of 

which could be masked in measuring these variables at the global level (i.e. 
the pressure-volume analysis). 
Recent work by Starling took the PVA analysis one step further by 
examining whether the use the PVA improves upon other hemodynamic based 
measures of myocardial work. Of relevance to this project was the finding that 
both the PVA and P-R product had a similar correlation to the MVO2. Thus, it 
was concluded that the PVA did not improve on the other indices of myocardial 
work [70]. The relative importance of this type of global analysis using the 
PVA was thus called into question since it fails to provide more useful 
information than methods clinically available (e.g. calculation of P-R 
product). 
Other investigators have approached the measurement of segmental 
myocardial work from a more regional level using the pressure-length (P-L) 
loop. Forrester et al. found a linear relationship between the area of the P-L 
loop and the stroke work suggesting that the area circumscribed within this 
loop was a valid index of segmental performance [8 1 ]. This type of validation 
was limited in that comparisons of work at the regional level were made to 
more global indices of cardiac function (i.e. the stroke work) [751. 
Recent work by Vinten-Johansen compared the pressure-length loop 
area at the transmural level to both segment shortening and regional MVO2 
after repetitive occlusion-reperfusion periods in the dog. This study was one of 
the first to quantitatively compare the P-L loop area to a metabolic index of 
regional work. The authors noted a strong positive correlation between the 
stroke work ( i.e. P-L loop area) and regional MVO2, both of which remained 
elevated in the face of dyskinesis and/or akinesis in the involved segment. 
The study, therefore, came to the conclusion that continued segmental work 
was partially responsible for previously noted discrepancies between segment 
shortening and regional MVO2 . While the goal of this study was not a 
validation of the P-L loop as an index of regional work, the good correlation 
with regional MVO2 partially supports this hypothesis. 
This thesis improves upon these earlier attempts using the pressure- 
length loop, by validating the use of the pressure-thickening loop against 
three independent markers of myocardial work. The first index to which the 
P-T loop was compared was the myocardial oxygen consumption (MVO2). The 
MVO2 has been shown to be linearly related to the inotropic state of the heart 
[82]. The findings in this thesis that the MVO2 steadily increased with graded 
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dobutamine are in agreement with these earlier observations. This is not 
surprising based upon the strong properties of dobutamine which increase 
cardiac work through inotropic and, to a lesser extent, chronotropic effects 
[22]. The strong interrelation between cardiac work and the MVO2 has made 
this index a "gold standard" for comparison for other indices of work. 
The other two indices of work used for comparison in this study are 
related to the hemodynamic performance of the heart. First, the pressure- 
rate product depends on changes in both heart rate and systolic arterial 
pressure, both of which have been shown to positively contribute to oxygen 
consumption and therefore cardiac work [831. Concern regarding the use of 
the P-R product to estimate the MVO2 and therefore work in a canine model 
using halothane anesthesia was addressed by Rooke. He was able to 
demonstrate that the P-R product was indeed a valid index of estimation of 
myocardial work despite halothane anesthesia [84]. The third index utilized in 
this study was the maximal value of the first derivative of left ventricular 
pressure with respect to time. Again, this index was also found to linearly 
relate to oxygen consumption and work [82]. Based on these findings, we felt 
that the excellent correlations noted between the P-T loop area at the 
transmural level and these indices of work provided an empirical validation of 
our approach to regional work. 
As alluded to earlier, the lack of both hemodynamic and metabolic 
information at the sub-transmural level led to the use of flow as the basis of 
comparison for the sub-transmural P-T loop areas. The significant 
correlations found at the transmural level between flow and the MVO2, P-R 
product and maximal dP/dt indicate that in this preparation, flow behaved as 
an approximate index of work for comparison to the P-T loop areas. 
Regional Differences in Loop Area vs. Flow Correlations 
At the sub-transmural level of analysis we noted an inconsistent 
pattern of correlations between microsphere determined blood flow and 
respective loop area. Specifically, microsphere flow and loop area failed to 
reach statistical significance for the endocardium in the LAD and the midwall 
in the LCX territory. The most likely explanation for these unexpected 
findings relate to statistical uncertainty associated with the small sample size. 
Numerous authors have shown that, under pathologic conditions, flow 
and thickening correlate best in the deeper myocardial layers , especially the 
endocardium. Under normal conditions however, one finds that flow and 

thickening correlate in both superficial and deeper myocardial layers. This is 
true under a variety of experimental conditions including ischemia, exercise 
and atrial-paced tachycardia [61-64,87,931. One would therefore expect that the 
pressure-thickening loop area, being derived from thickening data, would 
show the same relationship to flow. We are optimistic that with additional 
studies, this relationship will indeed hold true. 
Regional Differences in Changes in Loop Area With Dobutamine 
The results of this study would seem to indicate a different response to 
dobutamine between the LAD and LCX territories with respect to changes in 
the pressure-thickening loop areas. A priori, there would be no reason to 
expect a different response in one bed versus the other as both were studied 
under the same conditions. One explanation for this observation again lies in 
the small sample size used here. It is therefore possible, and to be expected, 
that with augmentation of study numbers, the observed responses to 
dobutamine would equalize. 
A second potential explanation could be that there were subtle 
differences in signal quality between the LAD and LCX territories. Since the 
LAD and LCX pressure-thickening loops are generated using the same intra¬ 
ventricular pressure, any difference in signal quality could adversely affect 
the quality, and therefore the area of the loops. As the LCX Doppler crystal 
occasionally lies close the pericardial cradle, movement of the pericardium 
against the crystal may affect signal quality in that region. Any difference 
inherent to signal quality between the LAD and LCX regions should be borne 
out as more experiments are performed. 
A third potential explanation may lie in the placement of the crystals on 
the epicardial surface of the left ventricle. The LCX crystal tends to be placed 
in a more basal position relative to the LAD crystal to avoid placement of the 
LCX crystal over a papillary muscle. There may be as yet undefined 
differences in contractile reserve between these crystal locations which could 
limit changes in the loop area with inotropic stimulation. 
Regional Function Analysis 
The use of the Doppler based method to assess myocardial thickening 
has several importance advantages when compared to the standard two-crystal 
transit time technique. To elaborate on those eluded to in the introduction, 
each will now be addressed separately. 
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The Doppler technique is less traumatic to the myocardium since each 
crystal is sutured only to the epicardium using a few sutures penetrating 0.5- 
1.0 mm into the wall. In contrast, implantation of the ultrasonic crystals 
requires a stab wound into the ventricle through which the crystal is 
tunneled into the wall. The crystal occupies a 2 mm3 space within the wall 
producing both edema at the stab wound and secondary distortion of the local 
fibers. The effects of this distortion are impossible to quantitate and may 
adversely affect the accurate measurement of segment length and thickening. 
The second and related advantage of the single crystal Doppler 
technique is that its proper function is affected less by changes in fiber 
orientation across the myocardial wall. The Doppler crystal directs its sound 
waves perpendicular to the myocardial wall, so changes in the fiber 
orientation across the wall should not affect the reflection of the sound pulse 
back to the probe. It has been shown that the myocardial fibers vary in 
orientation by about 1 10” from epicardium to endocardium [851. In order for 
the ultrasonic crystals to correctly assess changes in segment length they 
need to be positioned along the same shortening axis [86], Since the positions 
of the crystals can only be documented post-mortem, it is impossible to be 
confident of the crystal position during any given study. 
Furthermore, when the ultrasonic technique is employed to measure 
transmural wall thickening, the crystal within the myocardial wall is subject 
to the rotational effects of contraction which may displace the orientation of 
the crystals and adversely affect signal quality. While the Doppler crystal 
signal may be affected by the same rotational effects, it is unlikely that the 
Doppler signal would be affected to the same degree [42] 
The third and most significant advantage of the Doppler crystal 
technique lies in its unique ability to sample thickening at various levels 
across the myocardial wall at the same location. The amplitude of the 
thickening signals obtained in this thesis were found to be proportional to the 
position of the range gated sample volume. This is in good agreement with 
previous reports using the same technique [451 
Transmural Thickening Relations 
The transmural pattern of the calculated sub-transmural thickening 
fractions at baseline demonstrated a gradient favoring the endocardium, also 
in agreement with previous investigations [16, 44, 48-50], The finding that the 
%TF in the Endo and Mw tended to equalize with dobutamine has not been 
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previously reported using the Doppler crystal technique. A related study by 
Gallagher using the transit time technique examined how the inner 1/2 and 
outer 1/2 (of the wall) %TF changed with exercise. The results of that study 
indicated that the gradient in thickening function remained constant with 
exercise, always favoring the endocardium [87], The obvious difference 
between that study and this thesis is how the myocardial wall was divided for 
analysis. While the relationship between the Endo and Mw %TF was blurred 
during dobutamine in this study, the %TF for either of these was always 
greater than that in the Epi, supporting the constancy of the thickening 
gradient despite changes in myocardial performance. 
Hemodynamic effects of graded dobutamine 
In contrast to observations by other authors, we noted a much more 
dramatic response in the heart rate with graded dobutamine. Vatner reported 
that up to 40 ug/kg/min in a canine model that the heart rate increased 142% 
while we noted a 170% increase with a dose of only 15 ug/kg/min [88], A 
potential explanation lies in the fact that pentobarbital anesthesia as employed 
by Vatner et al. has potent myocardial depressant properties (89], Therefore, 
the heart rate response to dobutamine might have been blunted in comparison 
to that seen in this thesis where halothane anesthesia was employed. 
The response of the systemic vasculature observed in this study is in 
full accord with the literature. Dobutamine is known to stimulate both ax - and 
receptors in the vasculature [22]. These effects are felt to be relatively 
balanced resulting in little direct vascular effects. In this thesis, at the lower 
doses of dobutamine, mean AoP rose modestly (20%) then steadily declined as 
the level of dobutamine increased. The initial increase in systemic pressure 
was most likely related to the augmented inotropic state of the heart as 
evidenced by the early and pronounced increase in dP/dt (167% increase at 
D2.5 compared to baseline) and cardiac output (127% over baseline at D2.5) 
resulting in the higher systemic pressure. As the dose of dobutamine 
increased however, there was most likely a reflex withdrawal of sympathetic 
tone which resulted in a decrease in the vascular resistance (a 49% decline at 
D15.0 compared to baseline) and thus systemic arterial pressure. 
Dobutamine effects on the coronary circulation 
Dobutamine is also known to have effects on the canine coronary 
vasculature. We found a steady increase in Doppler epicardial LAD flow with 
graded dobutamine. This agrees with findings by other investigators that 
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epicardial coronary blood flow increases in parallel to demand with secondary 
coronary vasodilatation and decreased coronary resistance [90], Dobutamine 
was shown in this thesis to have produced a marked increase in myocardial 
contractile performance and therefore demand, thus explaining the 
significant increases in observed flow. 
At the sub-transmural level, we found that flow increased at all levels 
throughout graded dobutamine infusion with a gradient of flow favoring the 
epicardium in both perfusion territories. This gradient of flow is in contrast 
to that usually reported. Hoffman proposed after reviewing a number of 
experimental studies that the transmural gradient of flow was usually most 
altered in those models with an elaborate surgical preparation such as that 
used in this thesis [51]. The reasons for this are unclear, but may relate to 
changes in vagal tone and the use of halothane anesthesia. Vatner 
demonstrated that halothane (1 %) had a tendency to dilate the epicardial 
coronary vasculature. This tendency was partially offset by the cardiac 
depressant effects of halothane which tended to produce a decrease in 
metabolic demand, and therefore constrict the coronary bed [91]. Since flow 
reserve is known to be less in the subendocardium than the subepicardium, 
the combined effects of halothane could operate to produce the gradient of 
flow favoring the epicardium observed in this study. 
We noted in the post-dobutamine period that flow declined towards, but 
failed to return to, baseline values. While the half-life of intravenous 
dobutamine in humans is known to be about two minutes [22], no information 
is available regarding the half-life of the drug in dogs. It is therefore possible 
that the effects of dobutamine may persist beyond the time we expected and 
augmented flow and function 15 minutes (i.e. at the time of data collection) 
after maximal dobutamine had been terminated. Support for this theory could 
be taken from the fact that the heart rate, pressure-rate product, dP/dt, and 
cardiac output all behaved in a similar manner, failing to return to baseline 
after dobutamine was discontinued. It is also possible that the observations 
made here are an artifact of the small number of animals used for this study. 
Study Limitations 
Several potential sources of error may have adversely affected both data 
collection and analysis during the course of this project. The first and most 
important limitation of this thesis is the small number of experimental 
animals enrolled in the study. While pressure-thickening loop analysis has 
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been applied in more complex ischemic models in our laboratory, we chose a 
simpler, non-ischemic model to preliminarily define the role of the pressure¬ 
thickening loop as an index of changes in regional myocardial work. 
As this model depended on the use of anesthetized animals, any inter¬ 
animal differences could have accounted for the variability observed in the 
hemodynamic, flow and thickening responses to dobutamine. In addition, the 
use of in vivo models is frequently complicated by the need to exclude 
experimental animals from analysis for various technical reasons. This study 
was no exception with only 70% ( 5 of 7 ) of the animals originally enrolled in 
the study being included in the final data set. 
A limitation regarding the type of anesthesia used in this study lay in 
our inability to accurately measure the end-tidal concentration of halothane 
due to lack of equipment. This may have resulted in slightly different depths 
of anesthesia among the animals. While halothane is a known myocardial 
depressant, it has been shown that the most deleterious effects are not 
observed until an end-tidal concentration of 2% is reached [9 1 ]. The 
halothane concentration in this study was kept at an inspired concentration 
of 0.5-1.5%; if one assumes steady state conditions at the alveolar level, than it 
is unlikely that the halothane used in this study produced significant 
hemodynamic effects. 
With reference to the collection of the thickening data, Zhu et al. 
examined how the position of the range gated sample volume with reference to 
the true end-diastolic depth affected the %TF measurement. They were able to 
show that errors of 1 mm in either direction did not produce appreciable 
artifacts when validated in the two-crystal setup described in the introduction 
of this thesis [44]. 
An additional source of error which could not be easily controlled for 
was the signal quality obtained with the Doppler crystal. Most of this error 
was observed with the crystal located in the LCX territory, as evidenced by the 
need to exclude this data from one of the animals used in this study. While at 
post-mortem analysis, no crystal was noted to be situated over a papillary 
muscle, it was occasionally found that the crystal was at or near the edge of 
one. Since the papillary muscle produces a tangential force on the 
endocardial surface during its function, crystals which sample thickening 
near the insertion point could have artifacts related to the papillary muscle 
■ 
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function. This was rarely an issue in the LAD territory due the more basal and 
lateral position of the papillary muscles relative to the anterior wall. 
A methodologic limitation of the Doppler technique which was 
described earlier is the difficulty in quantifying the absolute left ventricular 
wall thickness. For the P-T loop analysis used here, this was not a problem 
since only the relative change in thickening (i.e. thickening excursion) was 
used to generate the loops. This inability to report true dimensions limits the 
application of real-world units of work to the area of the P-T loops. The loop 
area thus can only serve as a relative index of work, and not an absolute 
measure. The wall thickness could be estimated using the value of the range 
gate delay at which the blood pool was detected; however, this point would be 
difficult to consistently measure. This issue has recently been addressed with 
a new thickening module (Crystal Biotech, Holliston MA) which is able to 
reliably track the endocardial (or any other) point to give an accurate 
measure in millimeters of wall thickness. 
Several lines of investigation have evaluated the gradient of pressure 
across the myocardial wall [95-98] . While not conclusive, most studies have 
shown that a pressure gradient exists favoring the endocardium. If true, 
concern regarding the assumption of constant transmural intra-myocardial 
pressure inherent to this thesis could be raised. No attempts to quantitate 
intra-myocardial pressure were made during the course of this study due to 
the difficult and unreliable technical methods currently available for this 
purpose. If, however, one assumes that the gradient of pressure exists, then 
corresponding reductions would need to be made in the measured P-T loop area 
to compensate for the reduced pressure at the Endo, Mw and Epi sub-regions 
compared to the LVP as measured with the Millar® catheter located within the 
left ventricular cavity. 
A final methodologic limitation of this study is related to the 
determination of myocardial blood flow using the radiolabeled microsphere 
technique. Buckberg et al. summarized the potential errors associated with 
this technique and came to the conclusion that the error was minimized if (1) 
more than 400 microspheres were in each sample counted for flow (2) the 
microspheres were injected into the left atrium to ensure an even distribution 
in the bloodstream and (3) the microsphere technique was used in the dog. 
Since the microspheres are known to evenly distribute according to blood flow 
and at least 2 million microspheres were injected into the left atrium in this 
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canine model, then assuming that the heart receives 4% of its cardiac output 
we estimate that each of the 96 myocardial samples contained >400 
microspheres, well above the level established by Buckberg for accuracy [92], 
Future Applications 
This preliminary validation of the use of the pressure-thickening loop 
as an index of sub-transmural work supports further testing of this approach 
in other animal models. As stated earlier, we have applied this approach in 
two other model systems as part of pilot studies. We first applied it in a canine 
model of myocardial stunning (n=2) produced by a 15 minute complete 
occlusion of the LAD with three hours of reperfusion. The use of the P-T loop 
in this setting showed promise as a means to track the temporal sequence of 
functional recovery and its modification with dobutamine. We also applied 
this technique in a model of critical coronary stenosis (n=2) with dobutamine 
stimulation in an effort to obtain a better understanding of the flow-function 
relationship in the presence of a non flow-limiting stenoses. 
One aspect of the P-T loop which was not specifically addressed in this 
thesis was the change in loop morphology with dobutamine. We look forward 
to defining characteristic "loop responses" in shape as more data is collected 
on other animals since the limited number of animals in this study did not lend 
itself to this type of analysis. In addition, the P-T loop was not specifically 
analyzed with respect to the temporal sequence of contraction at the sub¬ 
transmural level. By superimposing temporally paired Endo, Mw and Epi loops 
on the same axes, it should be possible to examine the sequence of contraction 
across the myocardial wall. This analysis could also be applied to the raw 
thickening signal itself to obtain similar information. 
While this thesis looked primarily at indices of systolic function and 
work, the pressure-thickening loop has the potential to provide useful 
information on diastolic function as well. The diastolic segment of the loop 
could easily be analyzed with respect to temporal parameters of diastolic 
thinning such as (1) the mean rate to one-half end-diastolic thinning and (2) 
the late-diastolic thinning fraction. These type of analyses could provide 
important information regarding diastolic dysfunction and its modification 
with inotropic agents. 
Clinical Applications 
A recent paper by Bolli et al. reported on the use of a modified Doppler 
thickening crystal on humans undergoing coronary artery bypass graft 
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surgery. This crystal was attached to a suction cup which was then positioned 
on the cardiac surface to measure the thickening fraction before and after 
surgery. This allowed the investigators to monitor functional recovery across 
the myocardial wall after revascularization [47], The success of this 
application raises the possibility of generating P-T loops in the clinical setting 
during similar open chest procedures to monitor cardiac function and assess 
interventions aimed at maximizing function. 
Summary 
In this thesis, I have applied the use of a Doppler thickening crystal to 
generate sub-transmural left ventricular pressure-thickening loops which 
were first compared to independent indices of cardiac work and flow at the 
transmural level, then with flow at the level of the endocardium, midwall and 
epicardium with good results. The results of this analysis lend support to the 
use of these loops as a new index of regional work which provides information 
at a level of detail not available with other techniques. Future directions and 
potential clinical applications of this technique were outlined as well as the 
limitations of this approach. This type of approach will ultimately further the 
understanding of the complex interrelationship between myocardial flow, 
function and metabolism central to the management of patients with coronary 
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Fieure 1: Schematic drawing of the P-V diagram of the left ventricle. P-V loop 
is the tragectory of an ejecting contraction. The systolic segment (heavy 
curve) of the trajectory starts at a point on the end-diastolic P-V relation 
curve and ends at a point on the end-systolic P-V relation line. The 
rectangular area under the systolic segment of the P-V trajectory is 
equivalent to the external mechanical work of the contraction. The triangular 
area under the end-systolic P-V line between its volume intercept (Vd) and the 
end-systolic P-V point is equivalent to the end-systolic potential energy. The 







Figure 2: Instantaneous X-Y plots of left ventricular pressure vs. segmental 
length (mm) as measured with a segment length gauge. From left to right are 
pressure-length (P-L) loops under control, 10 seconds of ischemia and 30 min 




Figure 3: Pressure-length loop obtained from the LAD territory during mild 
ischemia. End-diastole (ED), defined by the initial upstroke of the first 
derivative of left ventricular pressure (dP/dt), and end-systole(ES) defined by 
the return of aortic flow to zero are indicated by vertical lines. ES = effective 
shortening area; PSS = post systolic shortening area; SL = systolic lengthening 
area (adapted from Safwat, 1991). 
Figure 4 ENDO 
EPI 
Figure 4: This schematic cut-away of a portion of the myocardial wall 
demonstrates the use of the epicardial Doppler crystal to measure thickening 
across the wall. The sample volume 0 is shown at three positions across the 
wall, corresponding to outer 1/3 (a), outer 2/3 (b) and transmural (i.e. full 
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Figure 8 (a-c) 
(a) 
LAD Tm Area 
( x 100%) 
(b) 
(c) 
Figure 8 (a-c): Shown here are the scatter plots with their respective 
correlations and significance levels for the LAD Transmural P-T loop area 
(LAD Tm Area) vs. the MVO2 (a), maximal dP/dt (b)t and P-R product (c). All 
data points are expressed as % change from baseline in order to facilitate 
incorporation of multiple animals into the data set. Of particular note are the 
good correlations observed between the Tm P-T loop area and the other 
variables. 
■ 




Figure 9 (a-b): In this figure are shown the scatter plots with their 
respective correlations and significance levels for the LCX transmural P-T loop 
area (LCX Tm area) vs. the maximal dP/dt (a) and P-R product (b). All data 
points are expressed as % change from baseline in order to facilitate 
incorporation of multiple animals into the data set. Again, good correlations 
were noted between the Tm loop area and hemodynamic indices of myocardial 
work. 






Figure 10 (a-d): In this figure, the scatter plots for the LAD transmural 
microsphere flow (LAD Tm flow) vs. the MVO2 (a), maximal dP/dt (b), P-R 
product (c), and Tm P-T loop area (LAD Tm Area) (d) are shown; again with 
their respective correlations and significance levels. All data points are 
expressed as % change from baseline in order to facilitate incorporation of 
multiple animals into the data set. As seen above, flow at the transmural level 
significantly correlated with both metabolic (MVO2) and hemodynamic 
(maximal dP/dt and P-R product) indices of myocardial work in addition to the 
P-T loop area. Flow thus appears to function as an indirect marker of work in 
this animal preparation. 

Figure J1 (a-c) 
(b) 
Similar to Figure 10 above, this figure depicts the scatter 
plots for the LCX transmural microsphere flow (LCX Tm flow) vs. the maximal 
dP/dt (a), P-R product (b) and Tm P-T loop area (c). Once again, significant 
correlations were found in all cases. As the M VO2 was only measured in the 
LAD territory, this metabolic index of work was not used for comparison to the 
LCX Tm flow. All data points are expressed as % change from baseline in order 
to facilitate incorporation of multiple animals into the data set. 

Figure 12 (a-c) 
(c) 
LAD Endo Flow 
( x 100%) 
(b) 
Figure 12 (a-c): In this figure, the respective sub-transmural (i.e. 
endocardial (a), midwall (b), and epicardial (c)) microsphere flows and P-T 
loop areas are compared for the LAD territory. While positive correlations 
were noted in all cases, statistical significance was only achieved for the 
midwall and epicardial sub-regions. All data points are expressed as % change 




Figure 13 (a-c) 
(a) 
LCX Endo Flow 
( x 100%) 
(b) 
(c) 
In this figure, the respective LCX territory sub-transmural 
(i.e. endocardial (a), midwall (b), and epicardial (c)) microsphere flows and P- 
T loop areas are compared. While positive correlations were again noted in all 
cases, in this case statistical significance was only achieved for the 
endocardial and epicardial sub-regions. All data points are expressed as % 
change from baseline in order to facilitate incorporation of multiple animals 
into the data set. 
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